Michels, S., Plenker, D., Wagener, S., Scheffler, M., Nogova, L., Abdulla, D., Riedel, R., Bunck, A., Merkelbach-Bruse, S., Buettner, R., Sos, M. and Wolf, J. (2017). Loss of ROS1 G2032R resistance mutation upon chemotherapy treatment enables successful crizotinib rechallenge in a ROS1-rearranged NSCLC patient. Oncol. Res. Treat., 40. S. 232 - 233. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Michels, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Plenker, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wagener, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Scheffler, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nogova, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Abdulla, D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Riedel, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bunck, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Merkelbach-Bruse, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Buettner, R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sos, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wolf, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-219155
Journal or Publication Title: Oncol. Res. Treat.
Volume: 40
Page Range: S. 232 - 233
Date: 2017
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/21915

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item